N-terminal modification is one of those subjects where the details matter more than the headlines. This page pulls together the background, the mechanisms, and the practical points readers ask about most.
Updated 2026-08-01. Numbers and descriptions here follow the published literature rather than marketing material.
Clinical interest in tesamorelin arose from the need to address visceral adiposity in people living with HIV. Antiretroviral therapy improved survival but was associated in some patients with central fat accumulation, altered lipid profiles, and metabolic complications. This condition, often called HIV-associated lipodystrophy, involves excess visceral adipose tissue that is difficult to manage through diet and exercise alone. Investigators evaluated tesamorelin because GHRH analogs can stimulate growth hormone secretion and influence fat distribution without direct liposuction or invasive procedures.
A Phase 3 program led to regulatory approval in the United States in 2010 for reduction of excess visceral abdominal fat in adults with HIV and lipodystrophy. Subsequent studies examined effects on liver fat, muscle area, and metabolic markers, with mixed findings for some endpoints. Long-term cardiovascular outcomes and effects on mortality remain uncertain because most trials were relatively short and focused on imaging-based fat measurements. Use in populations without HIV has been studied experimentally but is not part of the approved indication.
Tesamorelin is a synthetic peptide built from 44 amino acids and classified with the growth hormone–releasing hormone family. Its sequence corresponds to the human GHRH(1-44) backbone, carrying one structural change at the amino terminus. That change is a trans-3-hexenoyl group placed where the natural peptide would have an unmodified end. The modification is the feature that separates the compound from the endogenous hormone in name, in stability, and in how it is handled in the laboratory.
The hexenoyl cap slows the enzyme step that trims the amino terminus of native GHRH, the same step that shortens its active lifetime in circulation. As a result, the modified peptide persists longer in plasma than the unmodified hormone in side-by-side comparison. Receptor activity stays broadly comparable, because the added group sits away from the residues that contact the binding site. This combination, preserved receptor activity with reduced degradation, explains why the analog was developed instead of the native sequence.
Several compounds share the GHRH framework, including sermorelin, the shorter 1-29 fragment, and other analogs built on the full 1-44 chain. Naming follows a common convention: a stem that identifies the peptide plus a suffix marking analog status. Reports may describe tesamorelin by its sequence fragment, as a GHRH(1-44) analog, or by its amino-terminal modification. Indexing the compound therefore requires searching all of these forms, since some older literature predates the current international nonproprietary name.
| Property | Value | Notes |
|---|---|---|
| Molecular weight | Approximately 5,136 Da | Based on the 44-amino-acid peptide backbone and N-terminal modification. |
| Appearance | White to off-white lyophilized powder | Usually supplied in single-use vials for reconstitution. |
| Solubility | Freely soluble in water; slightly soluble in some organic solvents | Peptide nature supports aqueous reconstitution. |
| Typical storage | 2–8 °C, protected from light | Refrigeration reduces degradation; avoid freezing unless specified. |
| Common analytical method | Reverse-phase high-performance liquid chromatography | Used for identity, purity, and quantification. |
| Synonyms | Tesamorelin, TH9507, GHRH(1-44) analog | Generic descriptors; avoid proprietary names. |
Tesamorelin is a synthetic peptide of 44 amino acids that reproduces the sequence of human growth hormone-releasing hormone (GHRH) and carries a trans-3-hexenoyl group on its N-terminal tyrosine. That small fatty-acid modification blocks cleavage by dipeptidyl peptidase-4, the enzyme that rapidly degrades native GHRH in plasma. The result is a molecule with a longer circulating half-life than the natural hormone while retaining the same receptor target. It is supplied as a lyophilized powder for reconstitution and belongs to the broader class of GHRH analogs studied for effects on pituitary growth hormone secretion.
Development work on the compound, originally designated TH9507, focused on conditions in which reduced growth hormone signaling is thought to contribute to altered body composition. The United States Food and Drug Administration approved it in 2010 for the treatment of excess visceral abdominal fat in adults with human immunodeficiency virus infection and lipodystrophy. Later research examined other populations, including adults with mild cognitive impairment, where a large trial did not meet its primary endpoints. This mixed record illustrates how a single mechanism can produce clear effects in one setting and inconclusive results in another.
Several related peptides act on the same receptor, including sermorelin, a shorter GHRH fragment, and modified analogs such as CJC-1295 and modified GRF(1-29) that are common in research settings rather than approved products. Tesamorelin differs from growth hormone itself in that it acts upstream, prompting the pituitary to release the hormone through physiological signaling rather than supplying it directly. Terminology in the literature distinguishes GHRH analogs, growth hormone secretagogues, and recombinant growth hormone, although popular discussion often blurs these categories together. Precise naming matters when comparing study results.
Interest in this peptide developed because native GHRH has a short circulating lifetime. The N-terminal modification slows cleavage by dipeptidyl peptidase IV, an enzyme that removes the first two residues of many peptides and terminates their activity. Slower degradation means a longer window of receptor stimulation per administration. This design logic parallels other modified peptide hormones, where a small chemical change at a vulnerable site yields a more durable molecule without altering the core mechanism of action.
The peptide is synthesized chemically rather than extracted from biological sources. Solid-phase synthesis builds the chain from the C-terminus toward the N-terminus, after which the hexenoyl group is attached. Purity is typically assessed by high-performance liquid chromatography, and identity is confirmed by mass spectrometry. Regulatory review of the finished product focuses on these analytical controls, since small deviations in sequence or modification can change biological activity. Questions about long-term effects on the pituitary axis remain areas of continued investigation.
In such low-temperature environments, there is potential for preserving the original hydrogen isotope signal over hundreds of millions of years. However, many rocks in geologic time have reached significant thermal maturity. Even by the onset of the oil window it appears that much of the hydrogen has exchanged. Recently, scientists have explored a silver lining: hydrogen exchange is a zero order kinetic reaction (for carbon bound hydrogen at 80–100°C, the half-times are likely 104–105 years). Applying the mathematics of rate constants would allow extrapolation to original isotopic compositions. While this solution holds promise, there is too much disagreement in the literature for robust calibrations.
==== Omicron variant ==== During the emergence of the Omicron variant of COVID-19 in December 2021 and January 2022, Ford's government announced in December 2021 new restrictions on indoor settings. After growing calls for third or booster doses of COVID-19 vaccines, the government allowed all Ontarians over 18 years of age to receive a third dose on December 20, 2021. On January 3, 2022, Ford announced that Ontario would be moving into modified Step 2 on January 5, closing indoor dining, gyms, movie theatres and schools.
=== Classically activated macrophages === After receiving signaling from both IFNγ and TNF, macrophages acquire a phenotype with higher activity against both pathogens and tumor cells. They also secrete inflammatory cytokines. IFNγ signaling can initially originate from Natural Killer (NK) cells, but adaptive immune cells are required to sustain a population of classically activated macrophages. Toll-like receptor agonists may also cause macrophage activation.
Sources: en.wikipedia.org
A Komodo dragon may attempt to speed up the process by ramming the carcass against a tree to force it down its throat, sometimes ramming so forcefully that the tree is knocked down. A small tube under the tongue that connects to the lungs allows it to breathe while swallowing. After eating up to 80% of its body mass in one meal, it drags itself to a sunny location to speed digestion, as the food could rot and poison the dragon if left undigested in its stomach for too long. Because of their slow metabolism, large dragons can survive on as few as 12 meals a year. After digestion, the Komodo dragon regurgitates a mass of horns, hair, and teeth known as the gastric pellet, which is covered in malodorous mucus. After regurgitating the gastric pellet, it rubs its face in the dirt or on bushes to get rid of the mucus.
François Vandenesch; Timothy S Naimi; Mark Enright; et al. (2003). "Community-acquired methicillin-resistant Staphylococcus aureus carrying Panton-Valentine leukocidin genes: worldwide emergence". Emerging Infectious Diseases. 9 (8): 978–984. doi:10.3201/eid0908.030089. PMC 3020611. PMID 12967497. Wikidata Q24598936. Cameron Burton; Emma Best; Matthew Broom; Helen Heffernan; Simon Briggs; Rachel Webb (2023). "Pediatric Invasive Meningococcal Disease, Auckland, New Zealand (Aotearoa), 2004–2020". Emerging Infectious Diseases. 29 (4): 686–695. doi:10.3201/eid2904.221397. PMID 36957984. Wikidata Q130355931. Deborah A Williamson; Hanna E. Sidjabat; Joshua T Freeman; et al. (2012). "Identification and molecular characterisation of New Delhi metallo-β-lactamase-1 (NDM-1)- and NDM-6-producing Enterobacteriaceae from New Zealand hospitals". International Journal of Antimicrobial Agents. 39 (6): 529–533. doi:10.1016/j.ijantimicag.2012.02.017. PMID 22526013. Wikidata Q48050341. Joshua T Freeman; Stephen J McBride; Helen Heffernan; Tracy Bathgate; Chris Pope; Roderick B Ellis-Pegler (2008). "Community-onset genitourinary tract infection due to CTX-M-15-Producing Escherichia coli among travelers to the Indian subcontinent in New Zealand". Clinical Infectious Diseases. 47 (5): 689–692. doi:10.1086/590941. PMID 18665816. Wikidata Q45138244. Rajan P Adhikari; Gregory M Cook; Iain Lamont; Selwyn Lang; Helen Heffernan; John M B Smith (2002). "Phenotypic and molecular characterization of community occurring, Western Samoan phage pattern methicillin-resistant Staphylococcus aureus".
The new tools of molecular biology changed the study of bird systematics, which changed from being based on phenotype to the underlying genotype. The use of techniques such as DNA–DNA hybridization to study evolutionary relationships was pioneered by Charles Sibley and Jon Edward Ahlquist, resulting in what is called the Sibley–Ahlquist taxonomy. These early techniques have been replaced by newer ones based on mitochondrial DNA sequences and molecular phylogenetics approaches that make use of computational procedures for sequence alignment, construction of phylogenetic trees, and calibration of molecular clocks to infer evolutionary relationships. Molecular techniques are also widely used in studies of avian population biology and ecology.
Sources: en.wikipedia.org
Fresh meat can be vacuum-packed and skin-packed. Specialized packaging operations are needed to maintain product appearance and safety. Temperature control during the cold chain is needed for proper shelf life.
=== September 2005 === In a report published by Human Rights Watch in September 2005, U.S. Troops are accused to routinely torture prisoners in Iraq. Two sergeants and a captain describe e.g. the breaking of a detainee’s leg, and applying chemical substances to detainees’ skin and eyes. Capt. Ian Fishback of the 82nd Airborne who made persistent efforts over 17 months to raise concerns about detainee abuse with his chain of command was consistently told to ignore abuses and to “consider your career.” When he made an appointment with Senate staff members of Senators John McCain and John Warner, he says his commanding officer denied him a pass to leave his base.
James Upton (1670 in Wilmslow–1749), an English clergyman, schoolmaster and literary editor. Samuel Finney (1719 in Wilmslow–1798), an English miniature painter. William Ewart Gladstone (1809–1898), politician, statesman and Prime Minister four separate times, lived at the Wilmslow Rectory between January and April 1828 to study under the supervision of Reverend John Turner James Tait (1863–1944 in Wilmslow), medieval historian, noted for his retiring, scholarly life in Wilmslow Sir Thomas Barnes (1888–1964), lawyer and HM Procurator General and Treasury Solicitor 1934–1953 Helen Tolson (1888–1955), suffragette, active in the Women's Social and Political Union Alan Turing (1912–1954 in Wilmslow), computer science pioneer and driving force behind the Bombe machine for cracking the German Enigma cypher, is perhaps Wilmslow's most notable resident; he died locally In 2004, a blue plaque was placed on his house in his honour Patrick George (1923 in Wilmslow–2016), an English painter who taught at the Slade School of Fine Art Roger Thatcher (1926–2010), a British statistician, spent his formative early years in Wilmslow Antony Grey (1927 in Wilmslow–2010), pioneer gay rights activist Ronald Brunskill (1929–2015), architectural historian Rod Davies (1930–2015), astronomer and cosmologist, president of the Royal Astronomical Society, and director of Jodrell Bank Observatory Peter Emerson Jones (born 1935), owner of the Emerson Group, a property business lives locally Richard Evans (born 1945 in Wilmslow), a graphic designer, photographer and illustrator Iqbal Ahmed (born 1956), the owner and CEO of the Seamark Group's Asian food business, based in Manchester, lives in Wilmslow John Harris (born 1969 in Wilmslow), a British journalist, writer and critic.
Warning sirens were activated across northern Israel after reports emerged that up to 20 infiltrators on paragliders had entered Israeli territory from Lebanon before the IDF dismissed the report as a false alarm. Hezbollah deputy chief Sheikh Naim Qassem said "when time comes for any action, we will carry it out," stating that Hezbollah was ready and would contribute to confrontations against Israel according to its own plan. The IDF fired artillery, into southern Lebanon following an explosion that caused minor damage to a section of the Israel–Lebanon border wall near the kibbutz of Hanita. The IDF released footage of a drone attack which, according to them, killed three infiltrators from Lebanon near Margaliot who were members of Hamas. One of them was acknowledged by Hezbollah as one of their members. In the afternoon, Hezbollah fired 50 mortar shells and six anti-tank missiles towards five Israeli outposts in the Shebaa Farms. Further IDF shelling killed two civilians in a Shebaa village; video and photographic evidence showed usage of phosphorus bombs.
Sources: en.wikipedia.org
It is a synthetic peptide analog of human growth hormone-releasing hormone. It is used clinically to reduce excess visceral abdominal fat in adults with HIV-associated lipodystrophy. It works by stimulating pituitary growth hormone release.
Pivotal trials enrolled adults with HIV and excess visceral abdominal fat, often in the context of antiretroviral therapy. Participants were assessed mainly by computed tomography for visceral adipose tissue. The approved indication remains specific to that population.
Long-term effects on cardiovascular events, mortality, and sustained fat distribution are not well established. Most trials measured changes over months rather than years. Open questions also include whether benefits persist after treatment stops.
No. It is a peptide that acts upstream of growth hormone release, while growth hormone is the hormone itself. The two differ in size, in receptor, and in how the body clears them.